PA Turnpike, Department of Veterans Affairs launch health resource campaign
PENNSYLVANIA (WTAJ) — The U.S. Department of Veterans Affairs (VA) launched a new initiative with the Pennsylvania Turnpike Commission that will connect veterans in rural areas with health resources.
The PA Turnpike has posted flyers at rest areas across the road system that share easily accessible information about veterans' telehealth options, the closest VA location and the Veterans Crisis Line, which is a phone line that connects veterans to free, confidential support from trained responders.
The VA selected Pennsylvania to expand the initiative because of the state's size and rurality, with the department working closely with the PA Turnpike to provide information at all 17 service plazas.
'We are excited about this campaign, which will help Veterans access VA health care services and benefits they earned through their service to our country,' Tim Liezert, Network Director, VA Healthcare–VISN 4, said.
Rural healthcare can often be limited due to influxes in funding, care requirements and expansive geographics. The VA and PA Turnpike hope that this campaign will connect veterans with resources while maintaining a continuity of care within the health care system.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 hours ago
- Yahoo
Glassbeam Awarded FedRAMP Authorization for its SAAS analytics solution for connected medical systems by the U.S. Department of Veterans Affairs.
This designation enables Glassbeam to support federal government agency customers increase uptime for all MRI and CT scanners and avoid costly service delays. SANTA CLARA, Calif., June 13, 2025 /PRNewswire/ -- Glassbeam, Inc., a pioneer in data and predictive analytics for connected medical machines, today announced it has received FedRAMP authorization. Delivered as a service, Clinsights Service Analytics enables federal agencies, state and local governments, and providers of critical infrastructure to improve equipment availability and service productivity. The Federal Risk and Authorization Management Program (FedRAMP) is a federal government-wide program that provides a standardized approach to security assessment, authorization and continuous monitoring for cloud products and services. FedRAMP authorization follows a successful security audit via an accredited third-party assessor. "Glassbeam considers it a privilege to support the VA in its vital mission to serve Veterans. Achieving FedRAMP authorization for the VA demonstrates our unwavering commitment to the secure and careful handling of critical medical data. We are eager to continue our collaboration, enhancing the healthcare experience for those who have served.," according to Rich Jones, CEO of Glassbeam. Clinsights Service Analytics provides the only multi-vendor SaaS offering for proactive alerts in the federal marketplace, allowing federal organizations improve machine uptime, service engineer productivity and patient care by transforming maintenance services from break-fix to proactive-predictive through a highly scalable platform. Glassbeam recently partnered with the VHA Medical Device Networking and Cybersecurity Division and has supported the U.S. Department of Veterans Affairs with a deployment of Glassbeam Service Analytics within VISN 2. Unexpected equipment failures, lead to unplanned downtime which disrupts patient schedules, additional costs, and reduced access for imaging departments. With the completed authorization, Glassbeam is now listed on the FedRAMP Marketplace and increasing our work with the VA to deliver improved diagnosis and issue resolution. "We are excited to bring forward the technology to enable the monitoring and alerts for our valued customers, the VA clinicians." stated Garth Donaldson, Vice President of Sales, Glassbeam. Glassbeam uses artificial intelligence, predictive analytics, and machine learning to monitor medical devices, including MRI, CT scanners and other imaging equipment, in real-time to anticipate needed repairs and maximize uptime. Its ease of deployment and remote access option ensures operational efficiency while helping patients receive much-needed care, avoiding unnecessary delays. For more information, visit About GlassbeamGlassbeam is a pioneer in predictive analytics for medical devices. Our solutions enable improved uptime, utilization, and productivity by providing actionable insights. Glassbeam's cloud-based platform incorporates proprietary analytics and workflow to achieve tangible outcomes for organizations such as Canon Medical Systems USA, MultiCare Health System, Stanford, Brown's Medical Imaging, and Agiliti Health. For more information, visit Clinsights™ is a trademark of Glassbeam. Press ContactDave View original content to download multimedia: SOURCE Glassbeam, Inc. Sign in to access your portfolio
Axios
15 hours ago
- Axios
Where the 988 mental health hotline is used most — and least
Use of the 988 national suicide prevention and mental health hotline remains uneven across states, a new analysis finds. Why it matters: The service was launched nearly three years ago to help address America's mental health crisis — but gaps persist. Driving the news: Alaska (45.3 contacts per 1,000 people), Vermont (40.2) and New York (38.8) had the highest 988 contact rates among states in 2024, per new research published in JAMA Network Open. Delaware (12.5), Alabama (14.4) and Florida (15.6) had the lowest. The big picture: The 988 service fielded more than 16.3 million calls, texts and chats between July 2022 and the end of 2024. The national contact rate was 48.9 per 1,000 people during that period, and 23.7 in 2024 alone. How it works: "Contacts" include all calls, texts and chats sent to 988, including those forwarded along to more specific services, like the Veterans Crisis Line and the LGBTQ+ Line. Geography for calls and chats was assigned based on users' phone numbers, while texts were assigned by ZIP codes shared during pre-chat surveys. What they're saying: Several factors may be contributing to the state and regional differences in 988 use, says study author Jonathan Purtle, associate professor and director of policy research at New York University's School of Global Public Health. That includes differences in how 988 is being advertised by states and cities, as well as political attitudes. Many Americans remained unfamiliar with 988 as of last summer, per Ipsos polling. And surveys have found that Democrats are more likely than Republicans to use 988, Purtle says: "We see this shake out in the map — in the South and more right-leaning places, we see lower volume." Caveat: Less populous states have more variability due to their relatively smaller sample sizes, Purtle notes. The latest: The Trump administration's proposed Health and Human Services budget would cut 988 services specifically tailored for LGBTQ+ youth, Axios' Avery Lotz reports. What's next: Last year's nationwide 988 contact rate was less than half the rate of adult emergency room visits related to mental health, the analysis finds, despite ERs' cost and access issues.
Yahoo
a day ago
- Yahoo
ReShape Lifesciences® Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets
Recon Supply Named Exclusive U.S. Distributor of ReShape's STIMEL-03, Lap-Band® 2.0 FLEX, and Full Product Portfolio to Reach U.S. Veterans and Active-Duty Service Members IRVINE, Calif., June 12, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the signing of an exclusive U.S. distribution agreement with Recon Supply. Through this new strategic partnership, Recon Supply will distribute ReShape's cutting-edge portfolio, including the STIMEL-03 neuromuscular rehabilitation device, the next-generation Lap-Band® 2.0 FLEX, and the full range of ReShape products, across the Veterans Administration (VA) and Department of Defense (DoD) healthcare systems. This collaboration will expand access to proven, life-changing treatments for more than 18 million U.S. veterans and active military personnel. 'This agreement with Recon Supply marks a pivotal step forward in ReShape's mission to expand access to innovative medical technologies that improve lives,' stated Paul F. Hickey, President and Chief Executive Officer of ReShape Lifesciences. 'Through Recon's extensive footprint across the VA and DoD healthcare systems, we look forward to bringing our FDA-cleared STIMEL-03 system, a cutting-edge neurorehabilitation platform that is transforming clinical care with real-time EMG biofeedback and personalized electrical stimulation, to veterans and military personnel recovering from stroke, injury, or surgery. Additionally, the Lap-Band® 2.0 FLEX, our next-generation, minimally invasive weight loss solution, offers a safe, adjustable option for individuals struggling with obesity. Together, these technologies reflect our commitment to delivering high-impact, clinically proven solutions to patients in need, including those who have served our country.' 'Partnering with ReShape Lifesciences aligns perfectly with our mission to deliver innovative, life-changing medical solutions to those who have served our country,' added Steve Clark, Chief Executive Officer of Recon Supply and a U.S. Marine Corps veteran. 'With established access to VA and DoD facilities through our Distribution and Pricing Agreement (DAPA), Federal Supply Schedule (FSS), and Electronic Catalog (ECAT) contracts, this agreement allows us to expand the reach of ReShape's most impactful technologies—including the STIMEL-03 rehabilitation system and the Lap-Band® 2.0 FLEX. These solutions are well-suited to the complex needs of the veteran and active-duty populations we serve. Since relaunching in 2022, Recon Supply has grown over 113% year-over-year and now distributes to 102 VA Medical Centers nationwide, with a team made up almost entirely of veterans and veteran spouses. We are proud to partner with ReShape to bring these vital solutions to the men and women who have sacrificed for our country.' About Recon SupplyRecon Supply is a trusted distributor of medical products and technologies, specializing in providing high-quality solutions to federal agencies and healthcare systems. As a Service-Disabled Veteran-Owned Small Business (SDVOSB), Recon Supply is dedicated to delivering the most innovative medical technologies while actively supporting the veteran community through hiring initiatives. With a focus on excellence and reliability, Recon Supply is committed to enhancing patient care through innovative partnerships. For more information on Recon Supply, visit About ReShape Lifesciences® ReShape Lifesciences® is America's premier weight loss and metabolic health-solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease. The FDA-approved Lap-Band® System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. The investigational vagal neuromodulation system utilizes a proprietary vagus nerve block and stimulation technology platform for the treatment of type 2 diabetes and metabolic disorders. The Obalon® balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. For more information, please visit Forward-Looking Safe Harbor Statement This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from those discussed due to known and unknown risks, uncertainties, and other factors. These forward-looking statements generally can be identified by the use of words such as "expect," "plan," "anticipate," "could," "may," "intend," "will," "continue," "future," other words of similar meaning and the use of future dates. Forward-looking statements in this press release include statements about the expectations regarding the distribution arrangement of Recon Supply. These and additional risks and uncertainties are described more fully in the company's filings with the Securities and Exchange Commission, including those factors identified as "risk factors" in our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. We are providing this information as of the date of this press release and do not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise, except as required by law. CONTACTSReShape Lifesciences Investor Contact:Paul F. HickeyPresident and Chief Executive Officer949-276-7223ir@ Investor Relations Contact:Rx Communications GroupMichael Miller(917)-633-6086mmiller@ Errore nel recupero dei dati Effettua l'accesso per consultare il tuo portafoglio Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati
